Search Results - "Espuny Miró, Alberto"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Carboplatin dosing in obese patients by Ramírez-Roig, Cristina, Espuny-Miró, Alberto, Olmos-Jiménez, Raquel, Díaz-Carrasco, María Sacramento

    Published in Journal of oncology pharmacy practice (04-11-2024)
    “…The study aimed to: 1) Describe the carboplatin dosing criteria in obese patients in routine clinical practicein a general university hospital. 2) Evaluate…”
    Get full text
    Journal Article
  2. 2

    Predictive biomarkers of response to immune checkpoint inhibitors by Díaz-Carrasco, María Sacramento, González-Haba, Eva, García-Soler, Juana Inés, Espuny-Miró, Alberto

    “…The present paper provides a literature review aimed at  identifying the tumor-dependent factors capable of influencing a  subject's response to immune…”
    Get more information
    Journal Article
  3. 3

    Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients by Olmos-Jiménez, Raquel, Díaz-Carrasco, María Sacramento, Galera-Miñarro, Ana, Pascual-Gazquez, Juan Francisco, Espuny-Miró, Alberto

    Published in International journal of clinical pharmacy (01-02-2017)
    “…Background The administration of triple intrathecal therapy with methotrexate, cytarabine and a corticosteroid for the prophylaxis and treatment of neoplastic…”
    Get full text
    Journal Article
  4. 4

    Pharmacoepidemiological study of drug–drug interactions in onco-hematological pediatric patients by Fernández de Palencia Espinosa, M. Angeles, Díaz Carrasco, M. Sacramento, Fuster Soler, José Luis, Ruíz Merino, Guadalupe, De la Rubia Nieto, M. Amelia, Espuny Miró, Alberto

    Published in International journal of clinical pharmacy (01-12-2014)
    “…Background Onco-hematological patients are particularly susceptible to drug–drug interactions (DDIs) because they often undergo multiple combined treatments…”
    Get full text
    Journal Article
  5. 5

    Practical aspects of the use of intrathecal chemotherapy by Olmos-Jiménez, Raquel, Espuny-Miró, Alberto, Cárceles-Rodríguez, Carlos, Díaz-Carrasco, María Sacramento

    Published in Farmacia hospitalaria (01-01-2017)
    “…Intrathecal chemotherapy is frequently used in clinical practice for treatment and prevention of neoplastic meningitis. Despite its widespread use, there is…”
    Get full text
    Journal Article
  6. 6

    Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use by Olmos-Jiménez, Raquel, Espuny-Miró, Alberto, Díaz-Carrasco, María Sacramento, Fernández-Varón, Emilio, Valderrey-Pulido, Manuel, Cárceles-Rodríguez, Carlos

    Published in Journal of oncology pharmacy practice (01-10-2016)
    “…Introduction Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors by Fernández de Palencia Espinosa, Mª Ángeles, Díaz Carrasco, Mª Sacramento, Alonso Romero, José Luis, de la Rubia Nieto, Amelia, Espuny Miró, Alberto

    Published in International journal of clinical pharmacy (01-12-2015)
    “…Background Oncological patients are at high risk for drug–drug interactions (DDIs), which may contribute to therapeutic failure or lead to serious adverse…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Potential drug–drug interactions in hospitalised haematological patients by Fernández de Palencia Espinosa, Ma Ángeles, Díaz Carrasco, Ma Sacramento, Sánchez Salinas, Andrés, de la Rubia Nieto, Amelia, Miró, Alberto Espuny

    Published in Journal of oncology pharmacy practice (01-09-2017)
    “…Background Frequently, haematological patients undergo highly complex and intensive treatment protocols, so a high risk of drug–drug interactions could be…”
    Get full text
    Journal Article
  11. 11